Table of Content

1 Report Overview
1.1 Synthetic Opioids Definition
1.2 Market by Type
1.2.1 Global Synthetic Opioids Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Methadone
1.2.3 Fentanyl
1.2.4 Meperidine
1.2.5 Hydrocodone
1.2.6 Oxymorphone
1.2.7 Oxycodone
1.3 Market Segment by Application
1.3.1 Global Synthetic Opioids Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Pain Management
1.3.3 De-addiction
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Synthetic Opioids Sales
2.1 Global Synthetic Opioids Revenue Estimates and Forecasts 2018-2034
2.2 Global Synthetic Opioids Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Synthetic Opioids Revenue by Region
2.3.1 Global Synthetic Opioids Revenue by Region (2018-2023)
2.3.2 Global Synthetic Opioids Revenue by Region (2024-2034)
2.4 Global Synthetic Opioids Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Synthetic Opioids Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Synthetic Opioids Sales Quantity by Region
2.6.1 Global Synthetic Opioids Sales Quantity by Region (2018-2023)
2.6.2 Global Synthetic Opioids Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Synthetic Opioids Sales Quantity by Manufacturers
3.1.1 Global Synthetic Opioids Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Synthetic Opioids Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Synthetic Opioids Sales in 2024
3.2 Global Synthetic Opioids Revenue by Manufacturers
3.2.1 Global Synthetic Opioids Revenue by Manufacturers (2018-2023)
3.2.2 Global Synthetic Opioids Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Synthetic Opioids Revenue in 2024
3.3 Global Synthetic Opioids Sales Price by Manufacturers
3.4 Global Key Players of Synthetic Opioids, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Synthetic Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Synthetic Opioids, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Synthetic Opioids, Product Offered and Application
3.8 Global Key Manufacturers of Synthetic Opioids, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Synthetic Opioids Sales Quantity by Type
4.1.1 Global Synthetic Opioids Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Synthetic Opioids Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Synthetic Opioids Sales Quantity Market Share by Type (2018-2034)
4.2 Global Synthetic Opioids Revenue by Type
4.2.1 Global Synthetic Opioids Historical Revenue by Type (2018-2023)
4.2.2 Global Synthetic Opioids Forecasted Revenue by Type (2024-2034)
4.2.3 Global Synthetic Opioids Revenue Market Share by Type (2018-2034)
4.3 Global Synthetic Opioids Price by Type
4.3.1 Global Synthetic Opioids Price by Type (2018-2023)
4.3.2 Global Synthetic Opioids Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Synthetic Opioids Sales Quantity by Application
5.1.1 Global Synthetic Opioids Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Synthetic Opioids Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Synthetic Opioids Sales Quantity Market Share by Application (2018-2034)
5.2 Global Synthetic Opioids Revenue by Application
5.2.1 Global Synthetic Opioids Historical Revenue by Application (2018-2023)
5.2.2 Global Synthetic Opioids Forecasted Revenue by Application (2024-2034)
5.2.3 Global Synthetic Opioids Revenue Market Share by Application (2018-2034)
5.3 Global Synthetic Opioids Price by Application
5.3.1 Global Synthetic Opioids Price by Application (2018-2023)
5.3.2 Global Synthetic Opioids Price Forecast by Application (2024-2034)
6 North America
6.1 North America Synthetic Opioids Sales by Company
6.1.1 North America Synthetic Opioids Revenue by Company (2018-2023)
6.1.2 North America Synthetic Opioids Sales Quantity by Company (2018-2023)
6.2 North America Synthetic Opioids Market Size by Type
6.2.1 North America Synthetic Opioids Sales Quantity by Type (2018-2034)
6.2.2 North America Synthetic Opioids Revenue by Type (2018-2034)
6.3 North America Synthetic Opioids Market Size by Application
6.3.1 North America Synthetic Opioids Sales Quantity by Application (2018-2034)
6.3.2 North America Synthetic Opioids Revenue by Application (2018-2034)
6.4 North America Synthetic Opioids Market Size by Country
6.4.1 North America Synthetic Opioids Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Synthetic Opioids Revenue by Country (2018-2034)
6.4.3 North America Synthetic Opioids Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Synthetic Opioids Sales by Company
7.1.1 Europe Synthetic Opioids Sales Quantity by Company (2018-2023)
7.1.2 Europe Synthetic Opioids Revenue by Company (2018-2023)
7.2 Europe Synthetic Opioids Market Size by Type
7.2.1 Europe Synthetic Opioids Sales Quantity by Type (2018-2034)
7.2.2 Europe Synthetic Opioids Revenue by Type (2018-2034)
7.3 Europe Synthetic Opioids Market Size by Application
7.3.1 Europe Synthetic Opioids Sales Quantity by Application (2018-2034)
7.3.2 Europe Synthetic Opioids Revenue by Application (2018-2034)
7.4 Europe Synthetic Opioids Market Size by Country
7.4.1 Europe Synthetic Opioids Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Synthetic Opioids Revenue by Country (2018-2034)
7.4.3 Europe Synthetic Opioids Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Synthetic Opioids Sales by Company
8.1.1 China Synthetic Opioids Sales Quantity by Company (2018-2023)
8.1.2 China Synthetic Opioids Revenue by Company (2018-2023)
8.2 China Synthetic Opioids Market Size by Type
8.2.1 China Synthetic Opioids Sales Quantity by Type (2018-2034)
8.2.2 China Synthetic Opioids Revenue by Type (2018-2034)
8.3 China Synthetic Opioids Market Size by Application
8.3.1 China Synthetic Opioids Sales Quantity by Application (2018-2034)
8.3.2 China Synthetic Opioids Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Synthetic Opioids Sales by Company
9.1.1 APAC Synthetic Opioids Sales Quantity by Company (2018-2023)
9.1.2 APAC Synthetic Opioids Revenue by Company (2018-2023)
9.2 APAC Synthetic Opioids Market Size by Type
9.2.1 APAC Synthetic Opioids Sales Quantity by Type (2018-2034)
9.2.2 APAC Synthetic Opioids Revenue by Type (2018-2034)
9.3 APAC Synthetic Opioids Market Size by Application
9.3.1 APAC Synthetic Opioids Sales Quantity by Application (2018-2034)
9.3.2 APAC Synthetic Opioids Revenue by Application (2018-2034)
9.4 APAC Synthetic Opioids Market Size by Region
9.4.1 APAC Synthetic Opioids Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Synthetic Opioids Revenue by Region (2018-2034)
9.4.3 APAC Synthetic Opioids Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Synthetic Opioids Sales by Company
10.1.1 Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Synthetic Opioids Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Synthetic Opioids Market Size by Type
10.2.1 Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Synthetic Opioids Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Synthetic Opioids Market Size by Application
10.3.1 Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Synthetic Opioids Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Synthetic Opioids Market Size by Country
10.4.1 Middle East, Africa and Latin America Synthetic Opioids Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Synthetic Opioids Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Purdue Pharma
11.1.1 Purdue Pharma Company Information
11.1.2 Purdue Pharma Overview
11.1.3 Purdue Pharma Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Purdue Pharma Synthetic Opioids Products and Services
11.1.5 Purdue Pharma Synthetic Opioids SWOT Analysis
11.1.6 Purdue Pharma Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Pfizer Synthetic Opioids Products and Services
11.2.5 Pfizer Synthetic Opioids SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Information
11.3.2 Janssen Pharmaceuticals Overview
11.3.3 Janssen Pharmaceuticals Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Janssen Pharmaceuticals Synthetic Opioids Products and Services
11.3.5 Janssen Pharmaceuticals Synthetic Opioids SWOT Analysis
11.3.6 Janssen Pharmaceuticals Recent Developments
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Information
11.4.2 Teva Pharmaceuticals Overview
11.4.3 Teva Pharmaceuticals Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Teva Pharmaceuticals Synthetic Opioids Products and Services
11.4.5 Teva Pharmaceuticals Synthetic Opioids SWOT Analysis
11.4.6 Teva Pharmaceuticals Recent Developments
11.5 Endo International
11.5.1 Endo International Company Information
11.5.2 Endo International Overview
11.5.3 Endo International Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Endo International Synthetic Opioids Products and Services
11.5.5 Endo International Synthetic Opioids SWOT Analysis
11.5.6 Endo International Recent Developments
11.6 West-Ward Pharmaceuticals
11.6.1 West-Ward Pharmaceuticals Company Information
11.6.2 West-Ward Pharmaceuticals Overview
11.6.3 West-Ward Pharmaceuticals Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 West-Ward Pharmaceuticals Synthetic Opioids Products and Services
11.6.5 West-Ward Pharmaceuticals Synthetic Opioids SWOT Analysis
11.6.6 West-Ward Pharmaceuticals Recent Developments
11.7 Mallinckrodt Pharmaceuticals
11.7.1 Mallinckrodt Pharmaceuticals Company Information
11.7.2 Mallinckrodt Pharmaceuticals Overview
11.7.3 Mallinckrodt Pharmaceuticals Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Mallinckrodt Pharmaceuticals Synthetic Opioids Products and Services
11.7.5 Mallinckrodt Pharmaceuticals Synthetic Opioids SWOT Analysis
11.7.6 Mallinckrodt Pharmaceuticals Recent Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Overview
11.8.3 Mylan Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Mylan Synthetic Opioids Products and Services
11.8.5 Mylan Synthetic Opioids SWOT Analysis
11.8.6 Mylan Recent Developments
11.9 Impax Laboratories
11.9.1 Impax Laboratories Company Information
11.9.2 Impax Laboratories Overview
11.9.3 Impax Laboratories Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Impax Laboratories Synthetic Opioids Products and Services
11.9.5 Impax Laboratories Synthetic Opioids SWOT Analysis
11.9.6 Impax Laboratories Recent Developments
11.10 Indivior
11.10.1 Indivior Company Information
11.10.2 Indivior Overview
11.10.3 Indivior Synthetic Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Indivior Synthetic Opioids Products and Services
11.10.5 Indivior Synthetic Opioids SWOT Analysis
11.10.6 Indivior Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Synthetic Opioids Value Chain Analysis
12.2 Synthetic Opioids Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Synthetic Opioids Production Mode & Process
12.4 Synthetic Opioids Sales and Marketing
12.4.1 Synthetic Opioids Sales Channels
12.4.2 Synthetic Opioids Distributors
12.5 Synthetic Opioids Customers
13 Market Dynamics
13.1 Synthetic Opioids Industry Trends
13.2 Synthetic Opioids Market Drivers
13.3 Synthetic Opioids Market Challenges
13.4 Synthetic Opioids Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Synthetic Opioids Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Methadone
Table 3. Major Manufacturers of Fentanyl
Table 4. Major Manufacturers of Meperidine
Table 5. Major Manufacturers of Hydrocodone
Table 6. Major Manufacturers of Oxymorphone
Table 7. Major Manufacturers of Oxycodone
Table 8. Global Synthetic Opioids Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Synthetic Opioids Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Synthetic Opioids Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Synthetic Opioids Revenue Market Share by Region (2018-2023)
Table 12. Global Synthetic Opioids Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Synthetic Opioids Revenue Market Share by Region (2024-2034)
Table 14. Global Synthetic Opioids Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 15. Global Synthetic Opioids Sales by Region (2018-2023) & (K Pcs)
Table 16. Global Synthetic Opioids Sales Market Share by Region (2018-2023)
Table 17. Global Synthetic Opioids Sales by Region (2024-2034) & (K Pcs)
Table 18. Global Synthetic Opioids Sales Market Share by Region (2024-2034)
Table 19. Global Synthetic Opioids Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 20. Global Synthetic Opioids Sales Quantity Share by Manufacturers (2018-2023)
Table 21. Global Synthetic Opioids Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Synthetic Opioids Revenue Share by Manufacturers (2018-2023)
Table 23. Global Synthetic Opioids Price by Manufacturers 2018-2023 (USD/Pcs)
Table 24. Global Key Players of Synthetic Opioids, Industry Ranking, 2021 VS 2024
Table 25. Global Synthetic Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Synthetic Opioids by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthetic Opioids as of 2024)
Table 27. Global Key Manufacturers of Synthetic Opioids, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Synthetic Opioids, Product Offered and Application
Table 29. Global Key Manufacturers of Synthetic Opioids, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Synthetic Opioids Sales Quantity by Type (2018-2023) & (K Pcs)
Table 32. Global Synthetic Opioids Sales Quantity by Type (2024-2034) & (K Pcs)
Table 33. Global Synthetic Opioids Sales Quantity Share by Type (2018-2023)
Table 34. Global Synthetic Opioids Sales Quantity Share by Type (2024-2034)
Table 35. Global Synthetic Opioids Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Synthetic Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Synthetic Opioids Revenue Share by Type (2018-2023)
Table 38. Global Synthetic Opioids Revenue Share by Type (2024-2034)
Table 39. Synthetic Opioids Price by Type (2018-2023) & (USD/Pcs)
Table 40. Global Synthetic Opioids Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 41. Global Synthetic Opioids Sales Quantity by Application (2018-2023) & (K Pcs)
Table 42. Global Synthetic Opioids Sales Quantity by Application (2024-2034) & (K Pcs)
Table 43. Global Synthetic Opioids Sales Quantity Share by Application (2018-2023)
Table 44. Global Synthetic Opioids Sales Quantity Share by Application (2024-2034)
Table 45. Global Synthetic Opioids Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Synthetic Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Synthetic Opioids Revenue Share by Application (2018-2023)
Table 48. Global Synthetic Opioids Revenue Share by Application (2024-2034)
Table 49. Synthetic Opioids Price by Application (2018-2023) & (USD/Pcs)
Table 50. Global Synthetic Opioids Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 51. North America Synthetic Opioids Revenue by Company (2018-2023) & (US$ Million)
Table 52. North America Synthetic Opioids Sales Quantity by Company (2018-2023) & (K Pcs)
Table 53. North America Synthetic Opioids Sales Quantity by Type (2018-2023) & (K Pcs)
Table 54. North America Synthetic Opioids Sales Quantity by Type (2024-2034) & (K Pcs)
Table 55. North America Synthetic Opioids Revenue by Type (2018-2023) & (US$ Million)
Table 56. North America Synthetic Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Synthetic Opioids Sales Quantity by Application (2018-2023) & (K Pcs)
Table 58. North America Synthetic Opioids Sales Quantity by Application (2024-2034) & (K Pcs)
Table 59. North America Synthetic Opioids Revenue by Application (2018-2023) & (US$ Million)
Table 60. North America Synthetic Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Synthetic Opioids Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 62. North America Synthetic Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 63. North America Synthetic Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Synthetic Opioids Sales Quantity by Country (2018-2023) & (K Pcs)
Table 65. North America Synthetic Opioids Sales Quantity by Country (2024-2034) & (K Pcs)
Table 66. Europe Synthetic Opioids Sales Quantity by Company (2018-2023) & (K Pcs)
Table 67. Europe Synthetic Opioids Revenue by Company (2018-2023) & (US$ Million)
Table 68. Europe Synthetic Opioids Sales Quantity by Type (2018-2023) & (K Pcs)
Table 69. Europe Synthetic Opioids Sales Quantity by Type (2024-2034) & (K Pcs)
Table 70. Europe Synthetic Opioids Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Synthetic Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Synthetic Opioids Sales Quantity by Application (2018-2023) & (K Pcs)
Table 73. Europe Synthetic Opioids Sales Quantity by Application (2024-2034) & (K Pcs)
Table 74. Europe Synthetic Opioids Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Synthetic Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Synthetic Opioids Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 77. Europe Synthetic Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Synthetic Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Synthetic Opioids Sales Quantity by Country (2018-2023) & (K Pcs)
Table 80. Europe Synthetic Opioids Sales Quantity by Country (2024-2034) & (K Pcs)
Table 81. China Synthetic Opioids Sales Quantity by Company (2018-2023) & (K Pcs)
Table 82. China Synthetic Opioids Revenue by Company (2018-2023) & (US$ Million)
Table 83. China Synthetic Opioids Sales Quantity by Type (2018-2023) & (K Pcs)
Table 84. China Synthetic Opioids Sales Quantity by Type (2024-2034) & (K Pcs)
Table 85. China Synthetic Opioids Revenue by Type (2018-2023) & (US$ Million)
Table 86. China Synthetic Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Synthetic Opioids Sales Quantity by Application (2018-2023) & (K Pcs)
Table 88. China Synthetic Opioids Sales Quantity by Application (2024-2034) & (K Pcs)
Table 89. China Synthetic Opioids Revenue by Application (2018-2023) & (US$ Million)
Table 90. China Synthetic Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Synthetic Opioids Sales Quantity by Company (2018-2023) & (K Pcs)
Table 92. APAC Synthetic Opioids Revenue by Company (2018-2023) & (US$ Million)
Table 93. APAC Synthetic Opioids Sales Quantity by Type (2018-2023) & (K Pcs)
Table 94. APAC Synthetic Opioids Sales Quantity by Type (2024-2034) & (K Pcs)
Table 95. APAC Synthetic Opioids Revenue by Type (2018-2023) & (US$ Million)
Table 96. APAC Synthetic Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Synthetic Opioids Sales Quantity by Application (2018-2023) & (K Pcs)
Table 98. APAC Synthetic Opioids Sales Quantity by Application (2024-2034) & (K Pcs)
Table 99. APAC Synthetic Opioids Revenue by Application (2018-2023) & (US$ Million)
Table 100. APAC Synthetic Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Synthetic Opioids Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 102. APAC Synthetic Opioids Revenue by Region (2018-2023) & (US$ Million)
Table 103. APAC Synthetic Opioids Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Synthetic Opioids Sales Quantity by Region (2018-2023) & (K Pcs)
Table 105. APAC Synthetic Opioids Sales Quantity by Region (2024-2034) & (K Pcs)
Table 106. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Company (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Synthetic Opioids Revenue by Company (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Type (2018-2023) & (K Pcs)
Table 109. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Type (2024-2034) & (K Pcs)
Table 110. Middle East, Africa and Latin America Synthetic Opioids Revenue by Type (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Synthetic Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Application (2018-2023) & (K Pcs)
Table 113. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Application (2024-2034) & (K Pcs)
Table 114. Middle East, Africa and Latin America Synthetic Opioids Revenue by Application (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Synthetic Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Synthetic Opioids Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Synthetic Opioids Revenue by Country (2018-2023) & (US$ Million)
Table 118. Middle East, Africa and Latin America Synthetic Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Country (2018-2023) & (K Pcs)
Table 120. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity by Country (2024-2034) & (K Pcs)
Table 121. Purdue Pharma Company Information
Table 122. Purdue Pharma Description and Overview
Table 123. Purdue Pharma Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 124. Purdue Pharma Synthetic Opioids Product and Services
Table 125. Purdue Pharma Synthetic Opioids SWOT Analysis
Table 126. Purdue Pharma Recent Developments
Table 127. Pfizer Company Information
Table 128. Pfizer Description and Overview
Table 129. Pfizer Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 130. Pfizer Synthetic Opioids Product and Services
Table 131. Pfizer Synthetic Opioids SWOT Analysis
Table 132. Pfizer Recent Developments
Table 133. Janssen Pharmaceuticals Company Information
Table 134. Janssen Pharmaceuticals Description and Overview
Table 135. Janssen Pharmaceuticals Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 136. Janssen Pharmaceuticals Synthetic Opioids Product and Services
Table 137. Janssen Pharmaceuticals Synthetic Opioids SWOT Analysis
Table 138. Janssen Pharmaceuticals Recent Developments
Table 139. Teva Pharmaceuticals Company Information
Table 140. Teva Pharmaceuticals Description and Overview
Table 141. Teva Pharmaceuticals Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Teva Pharmaceuticals Synthetic Opioids Product and Services
Table 143. Teva Pharmaceuticals Synthetic Opioids SWOT Analysis
Table 144. Teva Pharmaceuticals Recent Developments
Table 145. Endo International Company Information
Table 146. Endo International Description and Overview
Table 147. Endo International Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Endo International Synthetic Opioids Product and Services
Table 149. Endo International Synthetic Opioids SWOT Analysis
Table 150. Endo International Recent Developments
Table 151. West-Ward Pharmaceuticals Company Information
Table 152. West-Ward Pharmaceuticals Description and Overview
Table 153. West-Ward Pharmaceuticals Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 154. West-Ward Pharmaceuticals Synthetic Opioids Product and Services
Table 155. West-Ward Pharmaceuticals Synthetic Opioids SWOT Analysis
Table 156. West-Ward Pharmaceuticals Recent Developments
Table 157. Mallinckrodt Pharmaceuticals Company Information
Table 158. Mallinckrodt Pharmaceuticals Description and Overview
Table 159. Mallinckrodt Pharmaceuticals Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 160. Mallinckrodt Pharmaceuticals Synthetic Opioids Product and Services
Table 161. Mallinckrodt Pharmaceuticals Synthetic Opioids SWOT Analysis
Table 162. Mallinckrodt Pharmaceuticals Recent Developments
Table 163. Mylan Company Information
Table 164. Mylan Description and Overview
Table 165. Mylan Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 166. Mylan Synthetic Opioids Product and Services
Table 167. Mylan Synthetic Opioids SWOT Analysis
Table 168. Mylan Recent Developments
Table 169. Impax Laboratories Company Information
Table 170. Impax Laboratories Description and Overview
Table 171. Impax Laboratories Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 172. Impax Laboratories Synthetic Opioids Product and Services
Table 173. Impax Laboratories Synthetic Opioids SWOT Analysis
Table 174. Impax Laboratories Recent Developments
Table 175. Indivior Company Information
Table 176. Indivior Description and Overview
Table 177. Indivior Synthetic Opioids Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 178. Indivior Synthetic Opioids Product and Services
Table 179. Indivior Synthetic Opioids SWOT Analysis
Table 180. Indivior Recent Developments
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Synthetic Opioids Distributors List
Table 184. Synthetic Opioids Customers List
Table 185. Synthetic Opioids Market Trends
Table 186. Synthetic Opioids Market Drivers
Table 187. Synthetic Opioids Market Challenges
Table 188. Synthetic Opioids Market Restraints
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Synthetic Opioids Product Picture
Figure 2. Global Synthetic Opioids Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Synthetic Opioids Market Share by Type in 2024 & 2034
Figure 4. Methadone Product Picture
Figure 5. Fentanyl Product Picture
Figure 6. Meperidine Product Picture
Figure 7. Hydrocodone Product Picture
Figure 8. Oxymorphone Product Picture
Figure 9. Oxycodone Product Picture
Figure 10. Global Synthetic Opioids Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 11. Global Synthetic Opioids Market Share by Application in 2024 & 2034
Figure 12. Pain Management
Figure 13. De-addiction
Figure 14. Synthetic Opioids Report Years Considered
Figure 15. Global Synthetic Opioids Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Synthetic Opioids Revenue 2018-2034 (US$ Million)
Figure 17. Global Synthetic Opioids Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Synthetic Opioids Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Synthetic Opioids Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Synthetic Opioids Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Synthetic Opioids Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Synthetic Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Synthetic Opioids Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Synthetic Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Synthetic Opioids Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Synthetic Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Synthetic Opioids Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Synthetic Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Synthetic Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Synthetic Opioids Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Synthetic Opioids Revenue in 2024
Figure 33. Synthetic Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Synthetic Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Synthetic Opioids Revenue Market Share by Type (2018-2034)
Figure 36. Global Synthetic Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Synthetic Opioids Revenue Market Share by Application (2018-2034)
Figure 38. North America Synthetic Opioids Revenue Market Share by Company in 2024
Figure 39. North America Synthetic Opioids Sales Quantity Market Share by Company in 2024
Figure 40. North America Synthetic Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Synthetic Opioids Revenue Market Share by Type (2018-2034)
Figure 42. North America Synthetic Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Synthetic Opioids Revenue Market Share by Application (2018-2034)
Figure 44. North America Synthetic Opioids Revenue Share by Country (2018-2034)
Figure 45. North America Synthetic Opioids Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Synthetic Opioids Sales Quantity Market Share by Company in 2024
Figure 49. Europe Synthetic Opioids Revenue Market Share by Company in 2024
Figure 50. Europe Synthetic Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Synthetic Opioids Revenue Market Share by Type (2018-2034)
Figure 52. Europe Synthetic Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Synthetic Opioids Revenue Market Share by Application (2018-2034)
Figure 54. Europe Synthetic Opioids Revenue Share by Country (2018-2034)
Figure 55. Europe Synthetic Opioids Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 57. France Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 61. China Synthetic Opioids Sales Quantity Market Share by Company in 2024
Figure 62. China Synthetic Opioids Revenue Market Share by Company in 2024
Figure 63. China Synthetic Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Synthetic Opioids Revenue Market Share by Type (2018-2034)
Figure 65. China Synthetic Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Synthetic Opioids Revenue Market Share by Application (2018-2034)
Figure 67. APAC Synthetic Opioids Sales Quantity Market Share by Company in 2024
Figure 68. APAC Synthetic Opioids Revenue Market Share by Company in 2024
Figure 69. APAC Synthetic Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Synthetic Opioids Revenue Market Share by Type (2018-2034)
Figure 71. APAC Synthetic Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Synthetic Opioids Revenue Market Share by Application (2018-2034)
Figure 73. APAC Synthetic Opioids Revenue Share by Region (2018-2034)
Figure 74. APAC Synthetic Opioids Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 79. India Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Synthetic Opioids Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Synthetic Opioids Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Synthetic Opioids Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Synthetic Opioids Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Synthetic Opioids Revenue Share by Country (2018-2034)
Figure 88. Brazil Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Synthetic Opioids Revenue (2018-2034) & (US$ Million)
Figure 93. Synthetic Opioids Value Chain
Figure 94. Synthetic Opioids Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed